Sheehan’s syndrome presenting with panhypopituitarism and central diabetes insipidus: a case report (2024)

  • Chin-Fang Chen1,
  • Yu-Cheng Liang1,
  • Meng-Jie Tsai1 &
  • Horng-Yih Ou1

BMC Endocrine Disorders volume24, Articlenumber:120 (2024) Cite this article

  • 152 Accesses

  • Metrics details

Abstract

Background

Sheehan’s syndrome is a rare condition, which is classically characterized by anterior pituitary hypofunction following postpartum shock or hemorrhage. While diabetes insipidus (DI) is not commonly associated with Sheehan’s syndrome, we present a rare case of a multiparous female developing rapid-onset panhypopituitarism and DI following severe postpartum hemorrhage.

Case presentation

A previously healthy 39-year-old woman, gravida 5, para 4, presented with hypovolemic shock after vagin*l delivery, attributed to severe postpartum hemorrhage, necessitating emergent hysterectomy. Although her shock episodes resolved during hospitalization, she developed intermittent fever, later diagnosed as adrenal insufficiency. Administration of hydrocortisone effectively resolved the fever. However, she subsequently developed diabetes insipidus. Diagnosis of Sheehan’s syndrome with central diabetes insipidus was confirmed through functional hormonal tests and MRI findings. Treatment consisted of hormone replacement therapy, with persistent panhypopituitarism noted during a ten-year follow-up period.

Conclusions

Sheehan’s syndrome is a rare complication of postpartum hemorrhage. Central diabetes insipidus should be suspected, although not commonly, while the patient presented polyuria and polydipsia. Besides, the potential necessity for long-term hormonal replacement therapy should be considered.

Peer Review reports

Background

Sheehan’s syndrome is a rare condition, which is classically characterized by anterior pituitary hypofunction following postpartum shock or hemorrhage. While diabetes insipidus (DI), which instead involves the posterior pituitary peptide hormone, is not commonly associated with Sheehan’s syndrome [1, 2], we present a case of a multiparous female who experienced a unique combination of rapid onset of panhypopituitarism and DI following a episode of severe postpartum hemorrhage.

Case presentation

A previously healthy 39-year-old woman, gravida 5, para 4, at 41 weeks pregnant, was transferred to our emergency department in hypovolemic shock. Three hours earlier, she had delivered a healthy full-term male infant weighing 3500g through vagin*l delivery, without the use of any instruments or excessive uterine pressure. However, one hour after delivery, significant postpartum vagin*l bleeding occurred, despite receiving intravenous Oxytocin (40IU, IV) and Methylergonovine (0.8mg, IV). Consequently, she received a transfusion of 10 units of packed red blood cells (RBC) and 1 unit of fresh frozen plasma (FFP). The estimated blood loss was 3,000ml before transferring to our emergency department.

Upon arrival, the patient was presented with profound shock, including a body temperature of 34.8°C, respiratory rate of 30 breaths per minute, and undetectable blood pressure. Physical examination revealed stupor consciousness, pale conjunctiva, and severe respiratory distress. Initial laboratory findings showed hemoglobin 10.0g/dL, platelet 113,000 cells/mm3. Arterial blood gas analysis indicated pH 6.601, PCO2 104.9 mmHg, bicarbonate 10.4 mmol/L, and PO2 30 mmHg. Coagulation studies indicated prothrombin time 18.75/11.10s and an activated partial thromboplastin time 185.55/28.9s. Due to her critical condition, an emergent hysterectomy was performed, revealing a laceration of the right uterine artery, with a substantial transfusion of 9 units of whole blood, 37 units of packed RBC, 36 units of platelets, and 36 units of FFP, due to intraoperative blood loss of 11,300ml. Following the surgery, the patient was admitted to the intensive care unit.

The patient’s hospitalization became complicated when she developed catheter-related sepsis and the bloodstream infection caused by Enterococcus faecalis and oxacillin-resistant Staphylococcus sciuri. Additionally, she experienced disseminated intravascular coagulopathy, acute renal insufficiency, and ischemic hepatitis. Proper administration of fluids and antibiotics, including vancomycin, ampicillin and sulbactam, led to improvements in renal and liver function and the recovery from the shock episode. Despite completing a course of antibiotics, the patient experienced intermittent fever for 2–3 weeks. Subsequently, she was diagnosed with adrenal insufficiency based on low cortisol levels (8 AM/4 PM: 5.6/4.0µg/dL). The fever resolved after administering intravenous hydrocortisone 100mg daily. However, she soon developed polyuria on the 30th day, with a significant increase in urine output, up to 11,070ml/day. Given the clinical suspicion of Sheehan’s syndrome with DI, further investigations were conducted.

To assess anterior pituitary function, the patient underwent Insulin hypoglycemia/ thyrotropin-releasing hormone (TRH) test/ luteinizing hormone-releasing hormone (LHRH) test (Table1), which revealed adrenal insufficiency, growth hormone deficiency, secondary hypogonadism, and secondary hypothyroidism. Panhypopituitarism was diagnosed. Water deprivation/desmopressin tests (Table1) showed increased urine osmolarity and decreased urine amount post desmopressin (DDAVP) infusion. Central DI was confirmed.

Magnetic resonance imaging (MRI) of the sellar region (Fig.1) was performed one month postpartum, revealing a heterogeneous signal within the normal-sized pituitary gland, consistent with acute hemorrhage and necrosis. A follow-up sellar region MRI (Fig.1), at 10 years later, revealed a very small size of the remaining pituitary gland.

MRI for head with the focus in the sella with and without Gadolinium contrast medium. MRI for head with the focus in the sella, sagittal view without Gadolinium contrast medium (A), and with Gadolinium contrast medium (B), corneal view without Gadolinium contrast medium (C) and with Gadolinium contrast medium (D), revealed there was slight heterogeneous signal within the pituitary gland. The size of the pituitary gland was within normal range. There was no normal enhancement of the gland itself except the pituitary stalk. The picture of hemorrhage and necrosis of the pituitary gland was compatible with Sheehan’s syndrome. Follow-up MRI of sellar region after 10 years, sagittal view without Gadolinium contrast medium (E), and with Gadolinium contrast medium (F), corneal view without Gadolinium contrast medium (G) and with Gadolinium contrast medium (H) revealed very small pituitary gland. The previous intra-glandular hemorrhage was not visualized this time. The pituitary stalk was in the midline

Full size image

Following the diagnosis of Sheehan’s syndrome with DI, the patient received intranasal desmopressin acetate 10 mcg BID, oral cortisone acetate 25mg BID, levothyroxine sodium 100 mcg QD, and conjugated estrogens 0.625mg QD to address the hormonal deficiencies. Over ten years of follow-up, her panhypopituitarism persisted, necessitating long-term hormone replacement therapy.

Discussion

Sheehan’s syndrome is classically characterized by reduced anterior pituitary hormone secretion following postpartum shock or hemorrhage. In 1963, Sheehan and Whitehead described varying degrees of pathological alterations including atrophy and scarring change in 90% of the posterior pituitary lobes from postpartum hypopituitary patients examined post mortem. Whitehead also reported constant hypothalamic damage characterized by marked atrophy of the supraoptic nuclei and, to a lesser extent, of the paraventricular nuclei, though, none of these patients had a history of transient DI [1].

Over the years, several studies had investigated antidiuretic function in patients with Sheehan’s syndrome [3,4,5,6,7,8]. Despite being asymptomatic for polyuria, most patients showed impaired osmoregulation of vasopressin secretion, including impaired maximal urine osmolality, insufficient urinary arginine vasopressin (AVP) excretion, elevated plasma osmolality, reduced urine-plasma osmolality ratios, and impaired plasma vasopressin response to plasma osmolality compared with normal control groups, both at baseline or after provocative test such as water deprivation / vasopressin or hypertonic saline infusion test. Patients also took a longer time to reach maximal urinary osmolality compared with normal subjects during functional tests.

From a clinical perspective, DI associated with Sheehan’s syndrome exhibits characteristic features. First, it tends to be partial rather than complete DI. Bakiri et al. and Jialal et al. reported that patients diagnosed with Sheehan’s syndrome and DI had a less than 50% increase in their maximal urine osmolality after water deprivation/vasopressin test [4,5,6]. Therefore, they concluded that failure of arginine-vasopressin secretion is more often partial. Atmaca, Tanriverdi et al. also disclosed that the patients diagnosed with DI all revealed partial DI. Hence, long term treatment of DI may be necessary in only a few cases.

Second, the onset of DI in Sheehan syndrome tends to be late, and the course tends to be transient. In Iwasaki’s series, only 4 of 12 had a history of transient symptomatic polyuria in their immediate postpartum period and one had DI for about 7 months after delivery. None of them developed permanent DI (all remission 10 months later). Robert L. at el. reported a case report with DI and Sheehan syndrome, and the interval between the postpartum hemorrhage and symptoms of polyuria was 11 years [9].

The reasons for DI to be partial and transient might be explained. The function of some vasopressin neurons that had been damaged as a result of the pituitary ischemic may recover. In addition, a decrease in the metabolism of vasopressin caused by disappearance of plasma vasopressinase that normally circulates during pregnancy also contributes. This enzyme is known to persist for 4–6 weeks after delivery. Finally, chronic deficiency of the hormone may lead to increased renal sensitivity to vasopressin.

Our case was diagnosed with adrenal insufficiency, which presented persistent fever on the 25th day after postpartum hemorrhage. Polyuria occurred soon after glucocorticoid replacement on the 30th day. Due to glucocorticoid deficiency, it is reasonable to presume that her DI might onset earlier than we noticed. After a water deprivation/desmopressin test, central DI, characterized by decreased release of AVP, was diagnosed. She was followed for years till now, and DDAVP therapy was still necessary for her to relieve polyuria. In comparison with the previously reported cases, the DI in this patient was unique as it occurred after steroid replacement for adrenal insufficiency, resulted in complete loss of antidiuretic function, had an early-onset, and was permanent in course.

Interestingly, although early research mostly suggested that DI was late onset, the fact is that early onset is not rare. Olmes, Solomayer et al. had performed a systematic review of Sheehan’s syndrome and DI, and identified eight relevant case reports published between 1990 and 2021 [10]. Most of the patients encountered severe blood loss, following hypotension or shock, similar to our case. The interval between birth and the initial manifestation of symptoms ranged from 24h to 19 days after delivery in all cases [2, 10,11,12,13,14,15,16,17]., with a median of 8.8 days. In our case, the patient developed symptoms on the 30th day. Five reports described accompanying hormone disorders with adrenal insufficiency, hypothyroidism and hypogonadism. Moreover, six reports mentioned the diagnosis of central DI, and the use of desmopressin to treat DI in the context of Sheehan’s syndrome.

The possible mechanism by which glucocorticoid replacement exacerbates DI is that glucocorticoids inhibit the synthesis of AVP in the hypothalamus through negative feedback. In return, hypocortisolism can result in elevated AVP levels and increased sensitivity to AVP [2, 18, 19]. Therefore, in our case, hypocortisolism might have initially masked the clinical manifestations of AVP deficiency; however, once steroid replacement therapy was initiated, the deficiency in AVP became symptomatic.

As for the pathogenesis of neurohypophyseal damage, it is difficult to determine. During pregnancy, the pituitary gland is enlarged physiologically [20]. Pituitary enlargement causes compression of the anterior hypophyseal artery, resulting in mild pituitary ischemia. Severe postpartum hemorrhage may lead to necrosis of the enlarged pituitary glands [12]. Typically, Sheehan’s syndrome presents initially as anterior pituitary hormonal dysfunction. Although most patients with Sheehan’s syndrome had atrophy of the posterior pituitary lobe and hypothalamic nuclei, AVP deficiency manifested as DI is very rare and occurs when a large portion of the neurohypophysis is destroyed [1]. However, it is still unclear whether DI is due to the posterior pituitary lobe damage or the insufficient hormone secretion by the hypothalamus.

Imaging study may offer an insight into such an issue. MRI imaging in our patient at the time of diagnosis revealed hemorrhage and necrosis of the pituitary gland, a distinct feature from previously reported ones. Originally, Sheehan’s syndrome was described as ischemic necrosis pathologically in the anterior pituitary following postpartum shock or hemorrhage without any image characteristics mentioned. However, depending on the time interval of event and image taking, non-hemorrhagic pituitary apoplexy [21] or empty sella have been the most common image finding in Sheehan’s syndrome. There were only few reports like ours on early image findings after postpartum hemorrhage in Sheehan’s syndrome. In a study measuring sella size and content in Sheehan’s syndrome by high resolution computerized tomography with time interval from postpartum hemorrhage to scan varied from 0.5 to 22 years (mean 11 years), an empty sella of a relatively small size was reported to be a common radiological finding, and the content varies from pituitary stalk only (26/57), stalk and other pituitary tissues (20/57), and a sella of pure CSF density (11/57) [22]. The hemorrhage of pituitary gland initially in our case might be due to hemorrhagic infarction or bleeding tendency because of complicated DIC course.

The extent of neurohypophyseal and adenohypophyseal defects was reported to be correlated. Iwasaki found 4 patients with very poor vasopressin response to hypertonic saline infusion had almost complete anterior pituitary hormone deficiency, where 4 other patients with normal or nearly normal vasopressin response had only partial or isolated anterior pituitary hormone deficiency [3]. Therefore, the risk for development of posterior pituitary dysfunction is increased if more complete loss of anterior pituitary hormone function loss exists [23]. It was applied to our case. Our patient suffered from anterior hypopituitarism with concurrent DI.

Conclusion

Sheehan syndrome is a rare complication of postpartum hemorrhage. Central diabetes insipidus should be suspected, although not commonly, while the patient presented polyuria and polydipsia. Besides, the potential necessity for long-term hormonal replacement therapy should be considered.

Full size table

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

DI:

diabetes insipidus

RBC:

red blood cells

FFP:

fresh frozen plasma

PCO2 :

partial pressure of carbon dioxide

PO2 :

oxygen partial pressure

DDAVP:

desmopressin

TRH:

thyrotropin-releasing hormone

LHRH:

luteinizing hormone releasing hormone

MRI:

magnetic resonance imaging

BID:

twice daily

QD:

every day

AVP:

arginine vasopressin

References

  1. Sheehan HL, Whitehead R. The neurohypophysis in post-partum hypopituitarism. J Pathol Bacteriol. 1963;85:145–69.

    Article PubMed CAS Google Scholar

  2. Kumar S, Burrows D, Dang S, Simmons D. Sheehan syndrome presenting as central diabetes insipidus: a rare presentation of an uncommon disorder. Endocr Pract. 2011;17(1):108–14.

    Article PubMed Google Scholar

  3. Iwasaki Y, Oiso Y, Yamauchi K, Takatsuki K, Kondo K, Hasegawa H, et al. Neurohypophyseal function in postpartum hypopituitarism: impaired plasma vasopressin response to osmotic stimuli. J Clin Endocrinol Metab. 1989;68(3):560–5.

    Article PubMed CAS Google Scholar

  4. Bakiri F, Benmiloud M, Vallotton MB. Arginine-vasopressin in postpartum panhypopituitarism: urinary excretion and kidney response to osmolar load. J Clin Endocrinol Metab. 1984;58(3):511–5.

    Article PubMed CAS Google Scholar

  5. Bakiri F, Benmiloud M. Antidiuretic function in Sheehan’s syndrome. Br Med J (Clin Res Ed). 1984;289(6445):579–80.

    Article PubMed CAS Google Scholar

  6. Jialal I, Desai RK, Rajput MC. An assessment of posterior pituitary function in patients with Sheehan’s syndrome. Clin Endocrinol (Oxf). 1987;27(1):91–5.

    Article PubMed CAS Google Scholar

  7. Arnaout MA, Ajlouni K. Plasma vasopressin responses in postpartum hypopituitarism: impaired response to osmotic stimuli. Acta Endocrinol (Copenh). 1992;127(6):494–8.

    PubMed CAS Google Scholar

  8. Atmaca H, Tanriverdi F, Gokce C, Unluhizarci K, Kelestimur F. Posterior pituitary function in Sheehan’s syndrome. Eur J Endocrinol. 2007;156(5):563–7.

    Article PubMed CAS Google Scholar

  9. Barbieri RL, Randall RW, Saltzman DH. Diabetes insipidus occurring in a patient with Sheehan’s syndrome during a gonadotropin-induced pregnancy. Fertil Steril. 1985;44(4):529–31.

    Article PubMed CAS Google Scholar

  10. Olmes GL, Solomayer EF, Radosa JC, Sklavounos P, Agne P, Schunk SJ, et al. Acute Sheehan’s syndrome manifesting initially with diabetes insipidus postpartum: a case report and systematic literature review. Arch Gynecol Obstet. 2022;306(3):699–706.

    Article PubMed Google Scholar

  11. Kuhn W, Krauß T. Das Sheehan-Syndrom, eine fast vergessene schwere komplikation post partum. Geburtshilfe Frauenheilkd. 1998;58(07):336–42.

    Article Google Scholar

  12. Dejager S, Gerber S, Foubert L, Turpin G. Sheehan’s syndrome: differential diagnosis in the acute phase. J Intern Med. 1998;244(3):261–6.

    Article PubMed CAS Google Scholar

  13. Kan AK, Calligerous D. A case report of Sheehan syndrome presenting with diabetes insipidus. Aust N Z J Obstet Gynaecol. 1998;38(2):224–6.

    Article PubMed CAS Google Scholar

  14. Wang HY, Chang CT, Wu MS. Postpartum hemorrhage complicated with irreversible renal failure and central diabetes insipidus. Ren Fail. 2002;24(6):849–52.

    Article PubMed Google Scholar

  15. Catinois ML, Chabre O, Chirossel C, Pellat J-M. Payen j-f. Le syndrome de Sheehan: un diagnostic difficile en post-partum immédiat. Annales Françaises d’Anesthésie et de Réanimation. 2004;23:508–12.

  16. Robalo R, Pedroso C, Agapito A, Borges A. Acute Sheehan’s syndrome presenting as central diabetes insipidus. BMJ Case Rep. 2012;2012.

  17. Rahmani Tzvi-Ran I, Olchowski J, Fraenkel M, Bashiri A, Barski L. A rare cause of postpartum acute hyponatremia. Endocrinol Diabetes Metab Case Rep. 2019;2019.

  18. Diederich S, Franzen NF, Bähr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol. 2003;148(6):609–17.

    Article PubMed CAS Google Scholar

  19. Laway BA, Mir SA, Dar MI, Zargar AH. Sheehan’s syndrome with central diabetes insipidus. Arq Bras Endocrinol Metabol. 2011;55(2):171–4.

    Article PubMed Google Scholar

  20. Goluboff LG, Ezrin C. Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab. 1969;29(12):1533–8.

    Article PubMed CAS Google Scholar

  21. Lavallée G, Morcos R, Palardy J, Aubé M, Gilbert D. MR of nonhemorrhagic postpartum pituitary apoplexy. AJNR Am J Neuroradiol. 1995;16(9):1939–41.

    PubMed Google Scholar

  22. Sherif IH, Vanderley CM, Beshyah S, Bosairi S. Sella size and contents in Sheehan’s syndrome. Clin Endocrinol (Oxf). 1989;30(6):613–8.

    Article PubMed CAS Google Scholar

  23. Sloper JC. Sheehan’s syndrome and diabetes insipidus. BMJ. 1963;1(5346):1679.

    Article PubMed PubMed Central CAS Google Scholar

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, No. 1 University Road, Tainan, 70101, Taiwan

    Chin-Fang Chen,Yu-Cheng Liang,Meng-Jie Tsai&Horng-Yih Ou

Authors

  1. Chin-Fang Chen

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  2. Yu-Cheng Liang

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  3. Meng-Jie Tsai

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  4. Horng-Yih Ou

    View author publications

    You can also search for this author in PubMedGoogle Scholar

Contributions

Chin-Fang Chen - designed the study, interpreted the data and drafted the manuscript. Yu-Cheng Liang - reviewed the manuscript. Meng-Jie Tsai - reviewed the manuscript. Horng-Yih Ou - coordinated the study and reviewed the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Horng-Yih Ou.

Ethics declarations

Ethical approval and consent to participate

The Institutional Review Board of National Cheng Kung University Hospital.

approved this study (Approval No.: A-EC-112-017).

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Sheehan’s syndrome presenting with panhypopituitarism and central diabetes insipidus: a case report (2)

Cite this article

Chen, CF., Liang, YC., Tsai, MJ. et al. Sheehan’s syndrome presenting with panhypopituitarism and central diabetes insipidus: a case report. BMC Endocr Disord 24, 120 (2024). https://doi.org/10.1186/s12902-024-01654-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12902-024-01654-w

Keywords

  • Adrenal insufficiency
  • Central Diabetes insipidus
  • Panhypopituitarism
  • Postpartum hemorrhagic shock
  • Sheehan’s syndrome
Sheehan’s syndrome presenting with panhypopituitarism and central diabetes insipidus: a case report (2024)

FAQs

What is Sheehan's syndrome central diabetes insipidus? ›

Although Sheehan syndrome is a known complication of postpartum hemorrhage, central diabetes insipidus is sel- dom considered or suspected. Hypovolemia is usually pre- sumed to be secondary to blood loss and polyuria resulting from a diuretic phase of acute renal failure.

What is Sheehan syndrome Panhypopituitarism? ›

Excessive blood loss during or after delivery of a baby may affect the function of the pituitary gland, leading to a form of maternal hypopituitarism known as Sheehan syndrome (SS). Such extensive bleeding may reduce the blood flow to the pituitary gland causing the pituitary cells to be damaged or die (necrosis).

What is a case of Sheehan's syndrome? ›

Sheehan syndrome which is also called post-partum pituitary necrosis refers to the necrosis of cells of the anterior pituitary gland following significant post-partum bleeding, hypovolemia, and shock. Advances in obstetrical care in developed countries have reduced the incidence of this condition.

What is hypopituitarism diabetes insipidus? ›

The pituitary gland and the hypothalamus are in the brain. They control hormone production. Diabetes insipidus happens when the body can't balance its fluid levels in a healthy way. Fluid in the blood is filtered through the kidneys to remove waste.

How do I know if I have Sheehan's syndrome? ›

Sheehan's Syndrome Symptoms

Some of the most common symptoms include: Difficulty breastfeeding or an inability to breastfeed. Decreased sex drive. Hypothyroidism (sensitivity to cold, weight gain, dry skin, joint pain and fatigue)

What is central diabetes insipidus? ›

Central diabetes insipidus (CDI) is a rare condition in which your body doesn't have enough antidiuretic hormone (ADH, or vasopressin), which causes you to pee large volumes of urine and become very thirsty. Your hypothalamus produces ADH, but your pituitary gland stores and releases it.

How serious is panhypopituitarism? ›

Yes, panhypopituitarism can be life-threatening, especially if you have a significant deficiency of adrenocorticotropic hormone (ACTH or corticotropin). Adrenal crisis (acute cortisol insufficiency) is a life-threatening complication of panhypopituitarism.

Can you recover from Sheehan syndrome? ›

Sheehan syndrome is rare but treatable with medication.

Does panhypopituitarism shorten life expectancy? ›

It typically involves treating the underlying cause of hypopituitarism with surgery while supplementing levels of the low hormone. Some people with hypopituitarism may have a reduced life expectancy. However, taking suitable medications and attending regular checkups can help improve lifespan.

What is the most common hormone affected in Sheehan's syndrome? ›

Growth hormone deficiency is one of the most common hormone deficiencies of hypopituitarism seen in Sheehan's syndrome. Low levels of growth hormone may present with low energy, body aches, or subtle wrinkling of the skin around the eyes or mouth.

Which drug is essential in Sheehan's syndrome? ›

Treatment for Sheehan syndrome is to take the hormones your body no longer produces. You'll need to stay on most of these hormones for life: Corticosteroids. Prednisone or hydrocortisone replaces adrenal hormones.

How to prevent Sheehan's syndrome? ›

Severe loss of blood during childbirth can often be prevented by proper medical care. Otherwise, Sheehan syndrome is not preventable.

Can diabetes insipidus be life threatening? ›

Diabetes insipidus usually doesn't cause serious problems. Adults rarely die from it as long as they drink enough water. But the risk of death is higher for infants, seniors, and those who have mental illnesses. That may be because they have trouble recognizing their thirst, or they can't do anything about it.

What is the root cause of diabetes insipidus? ›

Diabetes insipidus is caused by problems with a chemical called arginine vasopressin (AVP), which is also known as antidiuretic hormone (ADH). AVP is produced by the hypothalamus and stored in the pituitary gland until needed. The hypothalamus is an area of the brain that controls mood and appetite.

Can diabetes insipidus go away? ›

In some cases, nephrogenic diabetes insipidus may go away after treating its cause. For example, switching medicines or taking steps to balance the amount of calcium or potassium in your body may be enough to resolve the problem.

Does Sheehan syndrome affect ADH? ›

Hyponatremia is seen in many cases of Sheehan's syndrome because it can result from multiple etiologies. Drops in thyroid hormones and glucocorticoid/adrenal hormones can indirectly lead to hyponatremia through water retention, while blood loss can trigger hyponatremia through ADH secretion.

How does the pituitary gland cause diabetes insipidus? ›

When the level of water in your body decreases, your pituitary gland releases AVP to conserve water and stop the production of urine. In diabetes insipidus, AVP fails to properly regulate your body's level of water, and allows too much urine to be produced and passed from your body.

Which is associated with Sheehan syndrome? ›

Signs you may have Sheehan's syndrome

You may notice difficulty in breast feeding or a reduced milk supply, body hair may diminish, especially in under arm/pubic areas. You may have some weight gain or struggle to lose weight, and periods may be absent or irregular. You may also have dizziness and fatigue.

What is diabetes insipidus after pituitary apoplexy? ›

INTRODUCTION. Pituitary apoplexy is a relatively uncommon disorder characterized by hemorrhage or infarction of the pituitary gland. Numerous hormone deficiencies may occur after pituitary apoplexy, although diabetes insipidus is quite rare, occurring in only 3% of published reports.

Top Articles
Latest Posts
Article information

Author: Kimberely Baumbach CPA

Last Updated:

Views: 6146

Rating: 4 / 5 (61 voted)

Reviews: 84% of readers found this page helpful

Author information

Name: Kimberely Baumbach CPA

Birthday: 1996-01-14

Address: 8381 Boyce Course, Imeldachester, ND 74681

Phone: +3571286597580

Job: Product Banking Analyst

Hobby: Cosplaying, Inline skating, Amateur radio, Baton twirling, Mountaineering, Flying, Archery

Introduction: My name is Kimberely Baumbach CPA, I am a gorgeous, bright, charming, encouraging, zealous, lively, good person who loves writing and wants to share my knowledge and understanding with you.